David Stubbings

Chief Executive Officer

David Stubbings worked as a Medical Laboratory Scientific Officer (Clinical Chemistry) at the Royal London Hospital, Whitechapel and JSPS, Harley Street in London, England until 1986. He emigrated to South Africa and was employed as a Research assistant for the Natal Institute of Immunology until 1994 where he also completed his Masters degrees (1992). He joined NBI as Head of Products and Services then transferred to the Quality Division as Head of Quality Control and later became the Head of Quality Management and a member of the Senior Management Team. In November 2010 he was appointed Executive Director of NBI and in 2011, CEO of NBI.

Bronwyn Blades

Company Secretary

Bronwyn Blades is a qualified chartered accountant and has an MBA in Strategic Management. Bronwyn was employed by NBI as Financial Manager in August 2000, forming part of the senior management of the company. Bronwyn moved to SANBS as Financial Director in 2002. In 2006, when SANBS relocated its support services to Johannesburg, Bronwyn rejoined NBI, covering for the Financial Manager who was on maternity leave. Bronwyn has been the Company Secretary since 2007 and her responsibilities include strategy, risk management, corporate governance and project work. 

Sibusisiwe Zondi

Financial Director

Sibusisiwe Zondi is a qualified chartered accountant who was employed by NBI as Financial Manager in March 2003. Prior to this she was employed as an accountant at Robertsons (Pty) Ltd and Unilever.

Sibusisiwe is one of the 8 Senior Managers at NBI and is therefore jointly responsible for the strategy and the overall well-being of the company. As Head of Finance, Sibusisiwe is responsible for compliance to current accounting standards, internal and external audits, insurance and budgets, and treasury functions. The Procurement and IT departments are part of the Finance division and report to Sibusisiwe. Amongst her current responsibilities, she is a member of the Board of Trustees of the company’s provident fund and Chairperson of the Employment Equity Committee.

Dr Andrè Germishuizen, Pr. Eng

Head of Division: Quality Management and Scientific Affairs

Dr Andrè Germishuizen holds B.Eng and M.Eng degrees in chemical engineering from the University of Pretoria and a PhD in biochemical engineering from Cambridge University in the UK.

Andrè joined NBI in May 2013 as the Head of Quality Management and Scientific Affairs, where he is overall responsible for management of the Quality Division, and the maintenance and continuous improvement of the quality management system at NBI. As a member of the senior management team, he is responsible for modernising NBI’s product portfolio, manufacturing processes and application of science and engineering practices to enhance the way we work at NBI.

Before joining NBI, Andrè was the Chief Operating Officer of Animal Health Products at Deltamune in Pretoria, responsible for business aspects of Deltamune’s vaccine production and R&D facilities (personnel management, budget and legal issues), as well as operational management of the vaccine production facility. Prior to that, Andrè was the R&D manager at Medicine in Need South Africa (MEND), a subsidiary of a US non-profit company in Pretoria.

Pam Larkin

Strategic Resource and Market Development

Pam Larkin joined the NBI management team in 1994 as Head of Business Development. Pam qualified as a medical  technologist in the disciplines of Clinical Pathology and Microbiology and worked in these roles in both the private and state pathology sector before moving to the Natal Blood Transfusion Service (now part of SANBS) in 1991 as Marketing Manager.
Reporting directly to the Chief Executive Officer Pam’s current role is Head of Strategic Resources and Market Development at NBI, Pam is a member of the NBI Senior Management Team, and is responsible for ensuring the availability of NBI’s key strategic resources – human plasma and intermediate fractions where she identifies and negotiates supply agreements with plasma and plasma derived raw materials suppliers. Pam also manages the Export and Biotechnology departments. 

Dr Dale Gyure, Pr. Eng.

Strategic Development – Siyathuthuka Implementation

Dale Gyure completed his academic training at the University of Colorado in 1984 and has since accumulated 30 years’ experience in commercial biotechnology, process development, operations management, private consulting, university teaching and business venture development.  Dale joined NBI in 2010 as Head of Manufacturing to improve manufacturing capacity, compliance and technical competence within the Division and is currently assisting the CEO and Senior Management Team with strategic planning.  Dale presents short courses to industry in the pharmaceutical manufacturing sciences through the University of Stellenbosch. 

Rangini (Trisha) Chetty

Responsible Pharmacist

Trisha Chetty has more than 15 years’ work experience, including tenures in both the public and private health sector, at a managerial level. Trisha completed her Masters in Clinical Pharmacology in 2003, and joined NBI as Head: Information in 2007.  In 2013, Trisha was appointed as Responsible Pharmacist at NBI, where she is responsible for ensuring compliance with the Pharmacy Act (Act 53 of 1974), as amended, the Medicines and Related Substances Control Act (Act 101 of 1965), as amended, as well as with current Good Manufacturing Practice (cGMP) principles, licensing conditions and applicable legislation.  Further, as the Responsible Pharmacist, Trisha is accountable to the regulatory authorities, viz. the Medicines Control Council (MCC) and South African Pharmacy Council (SAPC), for ensuring that only products that satisfy the safety, quality and efficacy parameters are released for sale; and for providing a professional forum to maintain and enforce professional integrity and competence amongst pharmacists and pharmacist’s assistants at NBI.